Show Less

The Reconfiguration of a Latecomer Innovation System

Governing Pharmaceutical Biotechnology Innovation in South Korea


Dirk Johann

The book examines the evolving governance of pharmaceutical biotechnology in South Korea in order to derive conclusions about the dynamics of a latecomer system transition. Based on an analysis of innovation activities in the biomedical sector, which is complemented by expert interviews, the research contends that the Korean post-developmental state should be geared towards coordinating the interplay of technologies, modes of organization and institutions. An integrative framework is developed to describe system change as a co-evolutionary process in which the national and sectoral dimensions intersect. The case shows that the shaping of an environment in which innovation systems can develop sectoral transformative capacity is a central aspect of latecomer innovation governance.


Show Summary Details
Restricted access

3 Governance dimensions of technological learning and innovation in biotechnology


This chapter discusses the co-evolving institutional and organisational dynamics of biotechnology as a complex challenge for governance. The different governance dimensions concerning knowledge production and commercialisation o f emerging biotechnology are discussed in the context o f the continuously reshaping triadic relationships between government, science and industry. The chapter presents a generic perspective on the potential systemic failures and coordination gaps in the governance o f biotechnology between science and society. The chapter is divided in two parts: The first part discusses the political economy o f biotechnology with a focus on the technological and institutional- organisational co-evolution of the biotechnology regime and state policies that evolve in response to the regulatory needs for biotechnology. A central focus of the first part is the political economy o f biotechnology in Asia. The second part o f the chapter focuses on the configuration o f national innovation systems for the biotechnology regime. This part deals with the evolution o f science networks across industry boundaries and presents the interaction between scientific and organisational change in biotechnology and pharmaceuticals as a challenge for the configuration o f innovation systems. The second part also presents a generic concept for a biotechnology innovation system and discusses the implications for a latecomer innovation system. 128 The political economy o f biotechnology 3.1 The political economy of biotechnology 3.1.1 Technological and institutional-organisational co-evolution of the biotechnology regime The co-evolution of institutional frameworks and biotechnology firms The co-evolution of technology, industrial structure and institutions is an inherent...

You are not authenticated to view the full text of this chapter or article.

This site requires a subscription or purchase to access the full text of books or journals.

Do you have any questions? Contact us.

Or login to access all content.